RET-IN-8 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021093720A1 compound I-1. RET-IN-8 can be used for the research of cancer[1].
Molecular Weight:
486.57
CAS Number:
[2642164-75-6]
Formula:
C27H30N6O3
Target:
RET
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted